Instructions for Credit - There is no fee for this activity. In order to receive CME or CE credit, attendees must must view the program, complete the post-assessment with a score of 70% or higher, and complete the activity evaluation in order to obtain CE credit. After completing this process you will receive your certificate by email.

Target Audience:
This activity is intended for pediatric hematologist/oncologists, oncology nurses, social workers, and other healthcare professionals involved in the care of pediatric patients with hematologic malignancies.

Course content level for social workers: all levels

Learning Objectives:
At the conclusion of this activity, participants will be able to:

  • Describe common childhood blood cancers, including ALL and AML
  • Identify signs and symptoms of childhood blood cancers and diagnostic tests
  • Explain treatments, including the role of clinical trials, and LLS PedAL, a precision medicine clinical trial for pediatric acute leukemia
  • Describe strategies for management of short- and long-term side effects of treatment
  • Explain the importance of following a care plan, including long-term follow-up and communication between the pediatrician/family physician and the pediatric oncologist
  • Describe psychosocial concerns related to patients with pediatric cancer

Faculty:
Branko Cuglievan, MD
Assistant Professor, Pediatrics - Patient Care
Section Chief, Leukemia/Lymphoma
Children's Cancer Hospital
The University of Texas MD Anderson Cancer Center
Houston, TX

Romeo Torres, MSN, APRN, FNP-BC, CPHON
Pediatric Leukemia/Lymphoma
Children's Cancer Hospital
The University of Texas MD Anderson Cancer Center
Houston, TX

Joint Accreditation Statement:

 In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Leukemia & Lymphoma Society. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation of Credits:

Physician Continuing Medcial Educaiton

 The Postgraduate Institute for Medicine designates this CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registered Nursing Credit Designation

 Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Interprofessional Continuing Education

 This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

Continuing Physician Assistant Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Social Worker Continuing Education

 The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.0 continuing education credit.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1.0 CE clinical contact hour for this activity.

There are no fees for participating in or receiving credit for this activity.

Accredited Providers:
The associates of Postgraduate Institute for Medicine and The Leukemia & Lymphoma Society, the accredited providers for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity during the past 24 months.

Faculty Disclosures:
Branko Cuglievan, MD - Faculty Author/Course Committee has research funding from Astex, Kura Oncology, LLS, Octapharma, and Syndax, and travel/accomodations from Octopharma in the past 24 months
Romeo Torres, MSN, APRN, FNP-BC, CPHON - Faculty Author/Course Committee has no relevant financial disclosure in the past 24 months with any ineligible company
Lauren Berger, MPH - Planner/Course Committee has no relevant financial disclosure in the past 24 months with any ineligible company
Lesley Hoerst, BSN, RN - Planner/Course Committee has no relevant financial disclosure in the past 24 months with any ineligible company

Peer Reviewers
The Postgraduate Institute for Medicine planners and others have nothing to disclose.

Disclaimer:
The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Supporters:
There is no commercial support associated with this CME/CE activity.

System Requirements:
An active internet connection with Web browser is required to view this activity.



Estimated time to complete activity: 1.0 hour
Date of initial release: July 29, 2024
Valid for CME/CE credit through: January 29, 2026

For questions, concerns, or for assistance for people with disabilities or grievances, please contact ProfEducation@LLS.org